Laboratory network of excellence: enhancing patient safety and service effectiveness

Abstract Clinical laboratories have undergone major changes due to technological progress and economic pressure. While costs of laboratory testing continue to be the dominant issue within the healthcare service worldwide, quality, effectiveness and impact on outcomes are also emerging as critical value-added features. Five Italian laboratories are therefore promoting a network of excellence by investigating markers of effectiveness of laboratory services and sharing their experience of using them in clinical practice. In the present study we report preliminary data on indicators of quality in all phases of the so-called total testing process, the key to evaluating all phases of the total testing process, including the appropriateness of test requests and data interpretation. Initial findings in evaluating pre-analytical causes of specimen rejection in three different laboratories and the effects of introducing three laboratory clinical guidelines are reported. These data should stimulate debate in the scientific community and encourage more clinical laboratories to use the same indicators to improve clinical effectiveness and clinical outcomes within the healthcare service.

[1]  M Plebani.  Role of inspectors in external review mechanisms: criteria for selection, training and appraisal. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[2]  Howanitz Pj,et al.  Chemistry specimen acceptability: a College of American Pathologists Q-Probes study of 453 laboratories. , 1997 .

[3]  S. Chevret,et al.  From guidelines to hospital practice: reducing inappropriate ordering of thyroid hormone and antibody tests. , 2000, European journal of endocrinology.

[4]  Mario Plebani,et al.  Charting the course of medical laboratories in a changing environment. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[5]  Felix Redmill,et al.  System Safety: HAZOP and Software HAZOP , 1999 .

[6]  M Plebani,et al.  Error budget calculations in laboratory medicine: linking the concepts of biological variation and allowable medical errors. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[7]  R. Kyle,et al.  Monoclonal gammopathies of undetermined significance. , 2002, Reviews in clinical and experimental hematology.

[8]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[9]  M Plebani,et al.  The Changing Face of Clinical Laboratories , 1999, Clinical chemistry and laboratory medicine.

[10]  M Plebani,et al.  Hemolyzed specimens: a reason for rejection or a clinical challenge? , 2000, Clinical chemistry.

[11]  M. Field,et al.  Guidelines for Clinical Practice: From Development to Use , 1992 .

[12]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[13]  Mario Plebani,et al.  Errors in laboratory medicine. , 2002, Clinical chemistry.

[14]  Michael L Wilson.  Appropriate use of clinical microbiology tests. , 2002, Clinics in laboratory medicine.

[15]  A. Vleugels,et al.  [Guidelines for clinical practice]. , 1997, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.

[16]  P J Howanitz,et al.  Clinical laboratory quality control: a costly process now out of control. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[17]  Peter J Pronovost,et al.  How can clinicians measure safety and quality in acute care? , 2004, The Lancet.

[18]  M. Plebani,et al.  Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? , 2001, Annals of clinical biochemistry.

[19]  M. Laposata.  Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? , 2004, Clinical chemistry.

[20]  E. Braunwald,et al.  Acute coronary syndrome without ST elevation: implementation of new guidelines , 2001, The Lancet.

[21]  Robin A Felder,et al.  Evaluation of an automated preanalytical robotic workstation at two academic health centers. , 2002, Clinical chemistry.

[22]  R. Forsman,et al.  Why is the laboratory an afterthought for managed care organizations? , 1996, Clinical chemistry.

[23]  M. Plebani.  What information on quality specifications should be communicated to clinicians, and how? , 2004, Clinica chimica acta; international journal of clinical chemistry.

[24]  M Plebani,et al.  Mistakes in a stat laboratory: types and frequency. , 1997, Clinical chemistry.

[25]  C. Fraser.  Inherent biological variation and reference values , 2004, Clinical chemistry and laboratory medicine.

[26]  M. Plebani.  Towards quality specifications in extra-analytical phases of laboratory activity , 2004, Clinical chemistry and laboratory medicine.

[27]  R. Gräsbeck.  The evolution of the reference value concept , 2004, Clinical chemistry and laboratory medicine.

[28]  L. Demers,et al.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease , 2003, Clinical endocrinology.

[29]  P. H. Petersen,et al.  Analytical performance characteristics should be judged against objective quality specifications. , 1999, Clinical chemistry.

[30]  C. Price.  Evidence-based laboratory medicine: supporting decision-making. , 2000, Clinical chemistry.

[31]  E. Kilpatrick.  Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine , 2004, Annals of clinical biochemistry.

[32]  M. Usategui-Gomez,et al.  The use of polymerized antisera for the determination of human placental alkaline phosphatase in pregnancy sera. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[33]  Marco Pradella,et al.  Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. , 2002, American journal of clinical pathology.

[34]  Sverre Sandberg,et al.  Evidence-based guidelines in laboratory medicine: principles and methods. , 2004, Clinical chemistry.

[35]  P. H. Petersen,et al.  Reference values: from philosophy to a tool for laboratory medicine , 2004, Clinical chemistry and laboratory medicine.

[36]  D. Keren.  Antinuclear antibody testing. , 2002, Clinics in laboratory medicine.

[37]  Blanca Judith De la Fuente,et al.  Quality indicators and specifications for the extra-analytical phases in clinical laboratory management , 2004, Clinical chemistry and laboratory medicine.